Prot# NB19751A: A Double-Blind, Placebo-Controlledd Efficacy(as Assessed by Post-Bronchodilator FEV1) & Safety Study of 5mg R03300074 Once-Daily for 2 Years in Subjects with Smoking-Related, Moderate-to Severe COPD with Emphysema Receiving Optimal COPD Dr